Isaac Zentner

Isaac Zentner has worked in a variety of roles over the past 14 years. In 2006, they began as a Research Specialist at Drexel University College of Medicine. In 2010, they became a PhD Candidate at the same institution. In 2016, they became a Postdoctoral Fellow at Rutgers University. In 2019, they were an Associate Principal Scientist I at WuXi Advanced Therapies, where they were responsible for the development of early and late stage clinical manufacturing processes and commercial Cell Therapy manufacturing operations. In 2020, they joined Carisma Therapeutics, where they have held the roles of Manager, Process Development, Senior Manager, Process Development, and Associate Director, Process Development.

Isaac Zentner received a Bachelor of Science (B.S.) in Biochemistry and Molecular Biology from Dickinson College. Isaac then obtained a Doctor of Philosophy (PhD) in Molecular & Cell Biology & Genetics from Drexel University College of Medicine.